Login
| TI Ref No : | 522002526 |
|---|---|
| Description : | The Tk Aims To Conclude Discount Contracts According To ยง 130c Abs. 1 Sgb V For The Active Ingredient Combination Darunavir/cobicistat/emtricitabin/tenofovir Alafenamid With All Suitable Pharmaceutical Companies. The Contract Conclusion Takes Place Within |
| Date : | 2025-08-25 |
| Deadline : | 2026-02-19 |
| Document Type : | Tenders |
